Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jordi Junca"'
Autor:
Pablo Menendez, Maria Castella, Pedro Marín, Alex Bataller, Jordi Esteve, Diego Sánchez Martínez, Francisco Gutiérrez Agüera, Heleia Roca Ho, Clara Bueno, Matteo Libero Baroni, Talia Velasco Hernandez, Rafael Diaz de la Guardia, Julio Castaño, Eduardo Anguita, Susana Vives, Josep Nomdedeu, Helene Lapillone, Anne E Bras, Vincent H J van der Velden, Jordi Junca, Binje Vick, Irmela Jeremias, Angel Lopez, Marc Sorigue
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Acute myeloid leukemia (AML) is a hematopoietic malignancy which is biologically, phenotypically and genetically very heterogeneous. Outcome of patients with AML remains dismal, highlighting the need for improved, less toxic therapies. Chi
Externí odkaz:
https://doaj.org/article/b180785a65d94e76b264b5d5407bd47b
Autor:
Rebeca Jurado, Maria Huguet, Blanca Xicoy, Marta Cabezon, Ari Jimenez‐Ponce, David Quintela, Cristina De La Fuente, Minerva Raya, Esther Vinets, Jordi Junca, Joaquim Julià‐Torras, Lurdes Zamora, Albert Oriol, Jose‐Tomas Navarro, Xavier Calvo, Marc Sorigue
Publikováno v:
Cytometry Part B: Clinical Cytometry.
The presence of94% classical monocytes (MO1, CD14++/CD16-) in peripheral blood (PB) has an excellent performance for the diagnosis of chronic myelomonocytic leukemia (CMML). However, the monocyte gating strategy is not well defined. The objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b07d56018b2bca6081b82f64b92f6d8
https://doi.org/10.1002/cyto.b.22106
https://doi.org/10.1002/cyto.b.22106
Autor:
Mercè Aren, Silvia Marce, Rebeca Jurado, Gustavo Tapia, Lluís Puigdefabregues, Minerva Raya, Montserrat Cortes, Montse Garcia‐Caro, Jordi Junca, Pablo Mozas, Esther Viñets, Marta Cabezon, Esther Plensa, Milos Miljkovic, Juan‐Manuel Sancho, José‐Tomas Navarro, Lurdes Zamora, Marc Sorigue
Publikováno v:
Cytometry. Part B, Clinical cytometryREFERENCES. 102(6)
High-quality data on bone marrow involvement (BMI) assessed by flow cytometry (FC) in follicular lymphoma (FL) is lacking.We set up a prospective protocol with a 10-color tube and acquisition of 500.000 leukocytes on a Nav flow cytometer for evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20aad217683bf9cfa362078917c82777
https://pubmed.ncbi.nlm.nih.gov/36314855
https://pubmed.ncbi.nlm.nih.gov/36314855
Publikováno v:
International journal of laboratory hematologyREFERENCES. 44(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58c389fcc76a2c23e3ad2c9bd0c7ecc3
https://pubmed.ncbi.nlm.nih.gov/35000272
https://pubmed.ncbi.nlm.nih.gov/35000272
Autor:
Laura G.Rico, Andres Aguilar Hernandez, Michael D. Ward, Jolene A. Bradford, Jordi Junca, Rafael Rosell, Jordi Petriz
Immunohistochemicaland flow cytometric assessment of PD-L1 expression on tumor cells and immunecells might suppose a great benefit to identify patients undergoing immunotherapies. However, the use of different techniques and antibodies cancomplicate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2824de2a88a19667892835ad0741bc4
https://doi.org/10.31219/osf.io/qtj35
https://doi.org/10.31219/osf.io/qtj35
Autor:
Jolene A Bradford, Laura G. Rico, Jordi Junca, Jorge Bardina, Angel Bistue-Rovira, Michael D. Ward, Jordi Petriz
Publikováno v:
The Journal of Immunology. 204:145.25-145.25
Background Multiple myeloma (MM) is characterized by malignant plasma cells in the bone marrow with an associated immunosuppressive microenvironment. PD-L1 suppresses immune response and is overexpressed in MM plasma cells and MDSCs. PD-L1 plays an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bde84a333ffdab022caa118ce976dfa7
https://doi.org/10.4049/jimmunol.204.supp.145.25
https://doi.org/10.4049/jimmunol.204.supp.145.25
Autor:
Adrià Tort‐Merino, Neus Falgàs, Isabel E. Allen, Mircea Balasa, Jaume Olives, José Contador, Magdalena Castellví, Jordi Juncà‐Parella, Núria Guillén, Sergi Borrego‐Écija, Bea Bosch, Guadalupe Fernández‐Villullas, Oscar Ramos‐Campoy, Anna Antonell, Lorena Rami, Raquel Sánchez‐Valle, Albert Lladó
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 9, Iss 12, Pp 1962-1973 (2022)
Abstract Objectives Early‐ and late‐onset Alzheimer's disease (EOAD and LOAD) share the same neuropathological traits but show distinct cognitive features. We aimed to explore baseline and longitudinal outcomes of global and domain‐specific cog
Externí odkaz:
https://doaj.org/article/abe403be0281408b803f9a1bb91e097a
Publikováno v:
Cytometry. Part B, Clinical cytometry. 94(2)
Trisomy 12 chronic lymphocytic leukemia (CLL) is phenotypically different from the rest of CLL cytogenetic subgroups. However, it is unknown whether this is also the case for trisomy 12 CLL-phenotype monoclonal B-cell lymphocytosis (MBL).We analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a92a6672845332e3847d823054a01a2
https://pubmed.ncbi.nlm.nih.gov/28187524
https://pubmed.ncbi.nlm.nih.gov/28187524
Autor:
Laura G. Rico, Andrés Aguilar Hernández, Michael D. Ward, Jolene A. Bradford, Jordi Juncà, Rafael Rosell, Jordi Petriz
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100969- (2021)
Externí odkaz:
https://doaj.org/article/aba8c71271b5444db4c5142eebdb4cce
Autor:
Eulàlia Genescà, Mireia Morgades, Pau Montesinos, Pere Barba, Cristina Gil, Ramon Guàrdia, María-José Moreno, Daniel Martínez-Carballeira, Irene García-Cadenas, Susana Vives, Jordi Ribera, José González-Campos, Celia González-Gil, Lurdes Zamora, José-Luís Ramírez, Marina Díaz-Beya, Santiago Mercadal, María-Teresa Artola, Antònia Cladera, Mar Tormo, Arancha Bermúdez, Ferran Vall-Llovera, Pilar Martínez, María-Luz Amigo, Silvia Monsalvo, Andrés Novo, Marta Cervera, Antoni García-Guiñon, Jordi Juncà, Juana Ciudad, Alberto Orfao, Josep-Maria Ribera
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
Externí odkaz:
https://doaj.org/article/3d343883d8a5462d9d39b01b40bd0364